Russia to supply up to 35 million doses of Sputnik V vaccine to Uzbekistan
Russia’s sovereign wealth fund (RDIF) says it has agreed to supply up to 35 million doses of the Sputnik V vaccine to Uzbekistan.
RDIF said in a statement that upon approval by Uzbekistan’s regulators, up to 10 million doses of the vaccine will be delivered to Tashkent-based pharmaceutical company Laxisam in 2020. As many as 25 million doses will be shipped in 2021.
“Sputnik V is based on the human adenoviral vector platform, which has been studied over decades and in more than 250 clinical studies, proving its safety and effectiveness,” said Russian Direct Investment Fund CEO Kirill Dmitriev. “Supplies of the vaccine will ensure that medical specialists in the Republic of Uzbekistan have an advanced tool to combat the new coronavirus infection.”
RDIF said it had already reached supply agreements with Mexico, Brazil and India.
Russia was the first country to approve a coronavirus vaccine, but Moscow's claims were initially met with widespread concern and unanswered questions over the vaccine's safety, effectiveness and the speed at which it was developed.